⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28508385 | 0.89 | — | — | |
| SCHEMBL22228986 | 0.88 | — | — | |
| SCHEMBL11198457 | 0.88 | — | — | |
| SCHEMBL7069432 | 0.86 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL24423723 | 0.82 | KMT2A (0.34) | — | |
| SCHEMBL7184452 | 0.80 | SHBG (0.32) | — | |
| SCHEMBL3310474 | 0.78 | KCNA3 (0.31) | — | |
| SCHEMBL27795238 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL27774316 | 0.73 | — | — | |
| SCHEMBL16691785 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100191010-A1 | PROCESS FOR THE SYNTHESIS OF CARBAMATES USING CO2 | HUNTSMAN INTERNATIONAL LLC (US) | 2010-07-29 | — | — | US | claimed |
| EP-2173705-A1 | PROCESS FOR THE SYNTHESIS OF CARBAMATES USING CO2 | Huntsman International LLC (US) | 2010-04-14 | — | — | EP | claimed |
| WO-2009013062-A1 | PROCESS FOR THE SYNTHESIS OF CARBAMATES USING CO2 | HUNTSMAN INTERNATIONAL LLC (US) | 2009-01-29 | — | — | WO | claimed |
| EP-2011782-A1 | Process for the synthesis of carbamates using co2 | HUNTSMAN INTERNATIONAL LLC (US) | 2009-01-07 | — | — | EP | claimed |
| EP-4724441-A1 | ISOINDOLINONE AND DIHYDROPYRROLOPRIDINONE COMPOUNDS AND USES THEREOF | Revir Therapeutics, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4716531-A2 | HETEROCYCLIC COMPOUNDS AS NRAS INHIBITORS | Board of Regents, The University of Texas System (US) | 2026-04-01 | — | — | EP | disclosed |
| US-20260070925-A1 | HETEROCYCLIC COMPOUNDS AS NRAS INHIBITORS | UNIV TEXAS (US) | 2026-03-12 | — | — | US | disclosed |
| US-12509431-B2 | 1,4-dihydroquinazolinone compounds and uses thereof | EDGEWISE THERAPEUTICS, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250361213-A1 | 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF | EDGEWISE THERAPEUTICS INC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-4594307-A1 | 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF | EDGEWISE THERAPEUTICS, INC. (US) | 2025-08-06 | — | — | EP | disclosed |
| WO-2025133989-A1 | SMYD MODULATORS AND USES THEREOF | ALT-BIO PTE. LTD. (SG) | 2025-06-26 | — | — | WO | disclosed |
| EP-3217982-B1 | SPIROPYRAZINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH | HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH (DE) | 2025-05-28 | — | — | EP | disclosed |
| US-20070093414-A1 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2007-04-26 | — | — | US | disclosed |
| WO-2007044933-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-04-19 | — | — | WO | disclosed |
| US-7022871-B2 | Process for the synthesis of polycarbamates | HUNTSMAN INTERNATIONAL LLC (US) | 2006-04-04 | — | — | US | disclosed |
| EP-1242368-B1 | PROCESS FOR THE SYNTHESIS OF POLYCARBAMATES | HUNTSMAN INT LLC (US) | 2004-09-15 | — | — | EP | disclosed |
| US-20030135009-A1 | Process for the synthesis of polycarbamates | HUNTSMAN INTERNATIONAL LLC | 2003-07-17 | — | — | US | disclosed |
| EP-1242368-A2 | PROCESS FOR THE SYNTHESIS OF POLYCARBAMATES | HUNTSMAN INTERNATIONAL LLC (US) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001047871-A2 | PROCESS FOR THE SYNTHESIS OF POLYCARBAMATES | HUNTSMAN INTERNATIONAL LLC (US) | 2001-07-05 | — | — | WO | disclosed |
| US-6162824-A | NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | ALLELIX NEUROSCIENCE INC. | 2000-12-19 | — | — | US | disclosed |